A Study to Assess the Safety, Tolerability and Pharmacokinetics of Repeated Dosing Regimens of AL-794 in Healthy Volunteers

NCT03411421 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
27
Enrollment
INDUSTRY
Sponsor class

Stopped The study was closed as the data received to date did not support continuation of the study.

Conditions

Interventions

Sponsor

Alios Biopharma Inc.